Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)
Future research on EDC should prioritize a deeper understanding of inflammatory mechanisms, the development of precision medicine-based interventions, exploration of innovative therapies, and optimization of integrated management strategies
So far, early clinical data suggest amylin agonists offer milder side effects, and preclinical data support the hypothesis that their mechanism of action favors fat loss over lean mass loss
Brightening: Regular use of Vitamin C can help reduce the appearance of dark spots and hyperpigmentation, leading to a more even skin tone
Brand-name Ozempic and Wegovy face no such competition during patent protection, allowing the manufacturer to set prices without market pressure to reduce them